Publicaciones en las que colabora con Pedro Sánchez Rovira (12)

2022

  1. Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach

    Molecular Oncology, Vol. 16, Núm. 14, pp. 2658-2671

2021

  1. Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission

    Medicine, Vol. 100, Núm. 29, pp. e26533

2014

  1. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

    Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497

2013

  1. CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy

    International Journal of Cancer, Vol. 133, Núm. 10, pp. 2398-2407

2012

  1. Biomarkers characterization of circulating tumour cells in breast cancer patients

    Breast Cancer Research, Vol. 14, Núm. 3

2009

  1. Detection of circulating tumor cells in the context of treatment: Prognostic value in breast cancer

    Cancer Biology and Therapy, Vol. 8, Núm. 8, pp. 671-675

2006

  1. Olive oil in cancer prevention and progression

    Nutrition Reviews, Vol. 64, Núm. 10 SUPPL. 1

2005

  1. Declaración de Jaén 2004: Documento de consenso de la Conferencia Internacional sobre los Efectos Saludables del Aceite de Oliva Virgen

    Revista Espanola de Obesidad, Vol. 3, Núm. 4, pp. 212-217

  2. International conference on the healthy effect of virgin olive oil

    European Journal of Clinical Investigation, Vol. 35, Núm. 7, pp. 421-424

2004

  1. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

    Breast Diseases

2003

  1. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

    International Journal of Cancer, Vol. 107, Núm. 6, pp. 984-990

2002

  1. Evaluation of a gemcitabine-doxorubicin-paclitaxel combination schedule through flow cytometry assessment of apoptosis extent induced in human breast cancer cell lines

    Japanese Journal of Cancer Research, Vol. 93, Núm. 5, pp. 559-566